Carlos Alonso-Moreno
Overview
Explore the profile of Carlos Alonso-Moreno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
366
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ballestin P, Lopez de Sa A, Diaz-Tejeiro C, Paniagua-Herranz L, Sanvicente A, Lopez-Cade I, et al.
Pharmaceutics
. 2025 Feb;
17(2).
PMID: 40006625
Antibody-drug conjugates (ADCs) represent a novel therapeutic class that combines an antibody against a tumor-associated antigen (TAA), a payload, and a linker that binds these two components. Serious adverse events...
2.
Sevilla-Carrillo I, Garcia-Tercero E, Alonso-Moreno C, Moya-Lopez C
Anticancer Agents Med Chem
. 2025 Feb;
PMID: 39901681
Antibody-drug conjugates (ADCs) are a groundbreaking advancement in targeted cancer therapy, combining the precision of monoclonal antibodies with the potency of cytotoxic drugs. This review first outlines the components of...
3.
Kedjar N, Iannuzzi E, Kreuzer M, Alonso-Moreno C, Moya-Lopez C
Polymers (Basel)
. 2025 Jan;
17(1.
PMID: 39795526
The compounds targeting the bromo and extra terminal domain proteins (BET), such as the JQ1, present potent anti-cancer activity in preclinical models, however, the application of JQ1 at the clinical...
4.
Gueddari-Aourir A, Alonso-Moreno C, Zafrilla J, Canales-Vazquez J, Ayuso-Yuste M, Villasenor E, et al.
Environ Sci Pollut Res Int
. 2024 Aug;
PMID: 39088171
The Tetrahedron approach is a new environmental tool adapted to assess the sustainability of anthropogenic processes. This tool is based on a four-step methodology that includes (a) the identification of...
5.
Morata-Moreno N, Perez-Tanoira R, Del Campo-Balguerias A, Carrillo-Hermosilla F, Hernando-Gozalo M, Rescalvo-Casas C, et al.
Antibiotics (Basel)
. 2024 Jul;
13(7).
PMID: 39061291
The guanidine core has been one of the most studied functional groups in medicinal chemistry, and guanylation reactions are powerful tools for synthesizing this kind of compound. In this study,...
6.
Diaz-Tejeiro C, Arenas-Moreira M, Sanvicente A, Paniagua-Herranz L, Clemente-Casares P, Bravo I, et al.
Biomed Pharmacother
. 2024 Jul;
178:117165.
PMID: 39059354
Colorectal cancer (CRC) is the third most common cancer worldwide. Recent experiments suggest that CDK12 can be a good therapeutic target in CRC, and therefore, novel inhibitors targeting this protein...
7.
Ripoll C, Del Campo-Balguerias A, Alonso-Moreno C, Herrera-Ochoa D, Ocana A, Martin C, et al.
J Colloid Interface Sci
. 2024 Jun;
674:186-193.
PMID: 38925064
The effective measurement of temperature in living systems at the nano and microscopic scales continues to be a challenge to this day. Here, we study the use of 2-(anthracen-2-yl)-1,3-diisopropylguanidine, 1,...
8.
Dominguez-Jurado E, Ripoll C, Lara-Sanchez A, Ocana A, Vitorica-Yrezabal I, Bravo I, et al.
J Inorg Biochem
. 2024 Jan;
253:112486.
PMID: 38266323
The modular synthesis of the heteroscorpionate core is explored as a tool for the rapid development of ruthenium-based therapeutic agents. Starting with a series of structurally diverse alcohol-NN ligands, a...
9.
Del Campo-Balguerias A, Parra-Cadenas B, Nieto-Jimenez C, Bravo I, Ripoll C, Poyatos-Racionero E, et al.
Int J Mol Sci
. 2023 Sep;
24(18).
PMID: 37762123
The modular synthesis of the guanidine core by guanylation reactions using commercially available ZnEt as a catalyst has been exploited as a tool for the rapid development of antitumoral guanidine...
10.
Pacheco-Linan P, Alonso-Moreno C, Ocana A, Ripoll C, Garcia-Gil E, Garzon-Ruiz A, et al.
ACS Appl Mater Interfaces
. 2023 Sep;
15(38):44786-44795.
PMID: 37699547
AIEgens have emerged as a promising alternative to molecular rotors in bioimaging applications. However, transferring the concept of aggregation-induced emission (AIE) from solution to living systems remains a challenge. Given...